Cargando…

Synthesis, Characterization, and Preclinical Evaluation of New Thiazolidin-4-Ones Substituted with p-Chlorophenoxy Acetic Acid and Clofibric Acid against Insulin Resistance and Metabolic Disorder

We synthesized twenty thiazolidin-4-one derivatives, which were then characterized by standard chromatographic and spectroscopic methods. From the in vitro glucose uptake assay, two compounds behaved as insulin sensitizers, where they enhanced glucose uptake in isolated rat diaphragm. In high-carboh...

Descripción completa

Detalles Bibliográficos
Autores principales: Gowdra, Vasantharaju S., Mudgal, Jayesh, Bansal, Punit, Nayak, Pawan G., Manohara Reddy, Seethappa A., Shenoy, Gautham G., Valiathan, Manna, Chamallamudi, Mallikarjuna R., Nampurath, Gopalan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065710/
https://www.ncbi.nlm.nih.gov/pubmed/24995315
http://dx.doi.org/10.1155/2014/620434
_version_ 1782322129646125056
author Gowdra, Vasantharaju S.
Mudgal, Jayesh
Bansal, Punit
Nayak, Pawan G.
Manohara Reddy, Seethappa A.
Shenoy, Gautham G.
Valiathan, Manna
Chamallamudi, Mallikarjuna R.
Nampurath, Gopalan K.
author_facet Gowdra, Vasantharaju S.
Mudgal, Jayesh
Bansal, Punit
Nayak, Pawan G.
Manohara Reddy, Seethappa A.
Shenoy, Gautham G.
Valiathan, Manna
Chamallamudi, Mallikarjuna R.
Nampurath, Gopalan K.
author_sort Gowdra, Vasantharaju S.
collection PubMed
description We synthesized twenty thiazolidin-4-one derivatives, which were then characterized by standard chromatographic and spectroscopic methods. From the in vitro glucose uptake assay, two compounds behaved as insulin sensitizers, where they enhanced glucose uptake in isolated rat diaphragm. In high-carbohydrate diet-induced insulin resistant mice, these two thiazolidin-4-ones attenuated hyperglycemia, hyperinsulinemia, hypertriglyceridemia, hypercholesterolemia, and glucose intolerance. They raised the plasma leptin but did not reverse the diabetes-induced hypoadiponectinemia. Additionally, compound 3a reduced adiposity. The test compounds were also able to reverse the disturbed liver antioxidant milieu. To conclude, these two novel thiazolidin-4-ones modulated multiple mechanisms involved in metabolic disorders, reversing insulin resistance and thus preventing the development of type-2 diabetes.
format Online
Article
Text
id pubmed-4065710
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-40657102014-07-03 Synthesis, Characterization, and Preclinical Evaluation of New Thiazolidin-4-Ones Substituted with p-Chlorophenoxy Acetic Acid and Clofibric Acid against Insulin Resistance and Metabolic Disorder Gowdra, Vasantharaju S. Mudgal, Jayesh Bansal, Punit Nayak, Pawan G. Manohara Reddy, Seethappa A. Shenoy, Gautham G. Valiathan, Manna Chamallamudi, Mallikarjuna R. Nampurath, Gopalan K. Biomed Res Int Research Article We synthesized twenty thiazolidin-4-one derivatives, which were then characterized by standard chromatographic and spectroscopic methods. From the in vitro glucose uptake assay, two compounds behaved as insulin sensitizers, where they enhanced glucose uptake in isolated rat diaphragm. In high-carbohydrate diet-induced insulin resistant mice, these two thiazolidin-4-ones attenuated hyperglycemia, hyperinsulinemia, hypertriglyceridemia, hypercholesterolemia, and glucose intolerance. They raised the plasma leptin but did not reverse the diabetes-induced hypoadiponectinemia. Additionally, compound 3a reduced adiposity. The test compounds were also able to reverse the disturbed liver antioxidant milieu. To conclude, these two novel thiazolidin-4-ones modulated multiple mechanisms involved in metabolic disorders, reversing insulin resistance and thus preventing the development of type-2 diabetes. Hindawi Publishing Corporation 2014 2014-06-03 /pmc/articles/PMC4065710/ /pubmed/24995315 http://dx.doi.org/10.1155/2014/620434 Text en Copyright © 2014 Vasantharaju S. Gowdra et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gowdra, Vasantharaju S.
Mudgal, Jayesh
Bansal, Punit
Nayak, Pawan G.
Manohara Reddy, Seethappa A.
Shenoy, Gautham G.
Valiathan, Manna
Chamallamudi, Mallikarjuna R.
Nampurath, Gopalan K.
Synthesis, Characterization, and Preclinical Evaluation of New Thiazolidin-4-Ones Substituted with p-Chlorophenoxy Acetic Acid and Clofibric Acid against Insulin Resistance and Metabolic Disorder
title Synthesis, Characterization, and Preclinical Evaluation of New Thiazolidin-4-Ones Substituted with p-Chlorophenoxy Acetic Acid and Clofibric Acid against Insulin Resistance and Metabolic Disorder
title_full Synthesis, Characterization, and Preclinical Evaluation of New Thiazolidin-4-Ones Substituted with p-Chlorophenoxy Acetic Acid and Clofibric Acid against Insulin Resistance and Metabolic Disorder
title_fullStr Synthesis, Characterization, and Preclinical Evaluation of New Thiazolidin-4-Ones Substituted with p-Chlorophenoxy Acetic Acid and Clofibric Acid against Insulin Resistance and Metabolic Disorder
title_full_unstemmed Synthesis, Characterization, and Preclinical Evaluation of New Thiazolidin-4-Ones Substituted with p-Chlorophenoxy Acetic Acid and Clofibric Acid against Insulin Resistance and Metabolic Disorder
title_short Synthesis, Characterization, and Preclinical Evaluation of New Thiazolidin-4-Ones Substituted with p-Chlorophenoxy Acetic Acid and Clofibric Acid against Insulin Resistance and Metabolic Disorder
title_sort synthesis, characterization, and preclinical evaluation of new thiazolidin-4-ones substituted with p-chlorophenoxy acetic acid and clofibric acid against insulin resistance and metabolic disorder
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065710/
https://www.ncbi.nlm.nih.gov/pubmed/24995315
http://dx.doi.org/10.1155/2014/620434
work_keys_str_mv AT gowdravasantharajus synthesischaracterizationandpreclinicalevaluationofnewthiazolidin4onessubstitutedwithpchlorophenoxyaceticacidandclofibricacidagainstinsulinresistanceandmetabolicdisorder
AT mudgaljayesh synthesischaracterizationandpreclinicalevaluationofnewthiazolidin4onessubstitutedwithpchlorophenoxyaceticacidandclofibricacidagainstinsulinresistanceandmetabolicdisorder
AT bansalpunit synthesischaracterizationandpreclinicalevaluationofnewthiazolidin4onessubstitutedwithpchlorophenoxyaceticacidandclofibricacidagainstinsulinresistanceandmetabolicdisorder
AT nayakpawang synthesischaracterizationandpreclinicalevaluationofnewthiazolidin4onessubstitutedwithpchlorophenoxyaceticacidandclofibricacidagainstinsulinresistanceandmetabolicdisorder
AT manoharareddyseethappaa synthesischaracterizationandpreclinicalevaluationofnewthiazolidin4onessubstitutedwithpchlorophenoxyaceticacidandclofibricacidagainstinsulinresistanceandmetabolicdisorder
AT shenoygauthamg synthesischaracterizationandpreclinicalevaluationofnewthiazolidin4onessubstitutedwithpchlorophenoxyaceticacidandclofibricacidagainstinsulinresistanceandmetabolicdisorder
AT valiathanmanna synthesischaracterizationandpreclinicalevaluationofnewthiazolidin4onessubstitutedwithpchlorophenoxyaceticacidandclofibricacidagainstinsulinresistanceandmetabolicdisorder
AT chamallamudimallikarjunar synthesischaracterizationandpreclinicalevaluationofnewthiazolidin4onessubstitutedwithpchlorophenoxyaceticacidandclofibricacidagainstinsulinresistanceandmetabolicdisorder
AT nampurathgopalank synthesischaracterizationandpreclinicalevaluationofnewthiazolidin4onessubstitutedwithpchlorophenoxyaceticacidandclofibricacidagainstinsulinresistanceandmetabolicdisorder